Dermatology

2018 annual meeting of the American Academy of DermatologyThe American Academy of Dermatology annual meeting — Feb. 16-20 in San Diego — will highlight the status of new systemic treatments for chronic skin conditions, such as moderate-to-severe atopic dermatitis and psoriasis; in addition to new treatments for inflammatory skin conditions. Bookmark this site to follow the developments.
Widespread morphea treatment disparities signal need for guidelinesA survey of pediatric dermatologists and rheumatologists reveals wide variation in how patients with pediatric morphea are treated.
How to train for phone managementSpecific training criteria and phone management policy and procedures to help your dermatology practice blow the competition away.
AD therapy linked to ADHDAll children, but healthy controls, had a higher likelihood of behavioral issues. ADHD symptoms of attention, hyperactivity and impulse control, were higher in AD children. Quality of life lower in affected children.
How to avoid litigation associated with fillersLitigation is largely due to a practitioner’s lack of training and the lack of informed consent for the patient.
Pediatric psoriasis guidelinesPeDRA and NSP authors new consensus statement for pediatric psoriasis. Interdisciplinary care (dermatologist and pediatricians) is critical. Regular screening for common comorbidities is recommended.
Vascular compromiseAvoiding and treating vascular compromise with hyaluronic acid (HA) injections requires understanding the subtleties of underlying facial anatomy and keeping a well-stocked arsenal of treatments for impending necrosis.
EB’s great hopePediatricians respond to the first successful gene therapy treatment for epidermolysis bullosa.
Probiotics may improve pediatric AD symptomsA daily capsule of a cocktail of probiotics may reduce both the severity symptoms in moderate atopic dermatitis and the need for topical corticosteroids to treat symptom flare ups in children.
Pediatric dermatology updatesIn this article, Drs. Lawrence Eichenfield and Jessica Sprague review some of the most significant findings and developments in pediatric dermatology from the last year beginning with the availability of biologic agents for pediatric psoriasis and atopic dermatitis.